What Assessments Are Used for Bipolar Disorder?

Bipolar disorder is diagnosed through clinical assessment, not a blood test or brain scan. The process typically involves a combination of structured interviews, self-report questionnaires, mood-severity scales, and careful evaluation of a person’s history. No single tool confirms or rules out bipolar disorder on its own, and the diagnosis remains one of the trickiest in psychiatry, with misdiagnosis common enough that many people wait years before getting the right answer. Understanding what these assessments actually measure and where they fall short can make a real difference in how quickly someone gets appropriate care.

Structured Clinical Interviews

The gold standard for diagnosing bipolar disorder is a structured or semi-structured clinical interview conducted by a trained mental health professional. The most widely used is the Structured Clinical Interview for DSM-5, Clinician Version (SCID-5-CV). In this format, the clinician walks through a standardized set of questions covering mood episodes, psychotic symptoms, substance use, and other diagnostic categories, rather than relying on unstructured conversation alone. The SCID-5-CV shows strong agreement with independent clinical diagnoses. One validation study found that agreement between the SCID interviewer and psychiatric reports for bipolar and related disorders reached a kappa of 0.76 to 0.80, which reflects high consistency.¹ Another study found diagnostic sensitivity and specificity above 0.70 for most diagnoses, with positive agreement between the SCID and clinical diagnoses ranging from 73% to 97%.²

A shorter alternative is the Mini International Neuropsychiatric Interview (MINI), which takes considerably less time than the SCID and is commonly used in research and busy clinical settings. The trade-off is precision. In one study comparing the MINI to a full clinical interview in patients with mood disorders, the MINI had a sensitivity of about 87% for bipolar disorder but a specificity of only about 63%, with a kappa of 0.51.³ In practical terms, the MINI catches most people who have bipolar disorder but also flags a fair number who don’t. It works well as a starting point, less well as a final word.

Self-Report Screening Questionnaires

Before or alongside a clinical interview, many clinicians use brief self-report questionnaires to screen for bipolar disorder. The two most studied are the Mood Disorder Questionnaire (MDQ) and the Hypomania Checklist-32 (HCL-32). Both ask about past experiences of elevated mood, increased energy, reduced need for sleep, and other manic or hypomanic symptoms. They take just a few minutes to complete and can be filled out in a waiting room.

A meta-analysis comparing the two tools found that, using each study’s own cutoff scores, the HCL-32 had a sensitivity of about 82% and specificity of about 57%, while the MDQ had a sensitivity of about 80% and specificity of about 70%.⁴ The MDQ tends to be slightly better at correctly ruling out people who don’t have bipolar disorder, while the HCL-32 casts a somewhat wider net. Both tools have better negative predictive value than positive predictive value, meaning they are more reliable at telling you someone probably doesn’t have bipolar disorder than confirming that they do.⁵

Sensitivity for bipolar I disorder tends to be slightly higher than for bipolar II on both instruments, which makes sense: full-blown manic episodes are more memorable and dramatic than the subtler hypomanic episodes that define bipolar II.⁶ This is an important limitation. Many people with bipolar II spend most of their illness in depressive episodes and may not recognize their hypomanic periods as abnormal, which makes self-report screening inherently harder for this subtype.

Measuring How Severe an Episode Is

Screening tools and diagnostic interviews determine whether bipolar disorder is present. A separate category of instruments measures how severe a current episode is, which matters for treatment decisions and tracking progress over time. The Young Mania Rating Scale (YMRS) is the most widely used clinician-rated tool for mania. It covers items like elevated mood, increased motor activity, sexual interest, sleep disturbance, irritability, speech rate, thought content, disruptive behavior, appearance, and insight. The clinician scores each item during an interview, and the total gives a snapshot of manic symptom severity.

For the depressive side, the Montgomery-Åsberg Depression Rating Scale (MADRS) and the Hamilton Depression Rating Scale (HAM-D) are the most common choices. Both are clinician-administered and focus on symptoms like sadness, sleep disruption, appetite changes, concentration, and suicidal thoughts. These scales are among the most frequently used outcome measures in bipolar disorder clinical trials.⁷ A systematic review of studies in older adults with bipolar disorder confirmed that the YMRS was the most frequently used mania measure, while the HAM-D was among the most common depression measures.⁸

These severity scales don’t diagnose bipolar disorder. They quantify where someone sits on the spectrum from mild symptoms to a psychiatric emergency, and they give clinicians a standardized way to compare how a person is doing from one visit to the next.

Why Bipolar Disorder Gets Misdiagnosed So Often

One of the most persistent problems in bipolar assessment is that people are frequently diagnosed with something else first, usually unipolar depression. The reason is straightforward: most people with bipolar disorder seek help during a depressive episode, not during mania or hypomania. If the clinician doesn’t specifically ask about past episodes of elevated mood, increased energy, or decreased need for sleep, the bipolar component can go undetected. One large study found that the median time between a person’s first mental health diagnosis and receiving a bipolar diagnosis was 21 months, but for nearly a third of patients, the gap stretched to four years or more.⁹ During that delay, many patients are treated with antidepressants alone, which can worsen bipolar disorder by triggering manic or hypomanic episodes or accelerating mood cycling.

Misdiagnosis is not just inconvenient; it leads directly to ineffective treatment and worse outcomes.¹⁰ This is one reason that screening tools like the MDQ are recommended when someone presents with depression, especially if they have a family history of bipolar disorder, early age of onset, or a history of antidepressant-induced agitation.

Distinguishing Bipolar Disorder from Look-Alike Conditions

Beyond unipolar depression, two conditions create particular diagnostic confusion: attention-deficit/hyperactivity disorder (ADHD) and borderline personality disorder (BPD). All three share features like impulsivity, emotional instability, and difficulty concentrating. One study found that diagnostic overlap among bipolar disorder, ADHD, and borderline personality disorder reached 54%, with very similar levels of cyclothymic temperament across all three groups.¹¹

The key distinguishing feature of bipolar disorder is its episodic nature. Mood episodes have a clear beginning and end, with periods of relatively normal mood in between. ADHD and borderline personality disorder, by contrast, involve chronic, persistent patterns. ADHD symptoms like distractibility and restlessness are present from childhood and do not come and go in discrete episodes. Borderline personality disorder involves chronic emotional dysregulation along with hallmark features like an intense fear of abandonment, self-harm, chronic emptiness, and stress-related dissociation, none of which are characteristic of ADHD or bipolar disorder on their own.¹² Comorbidity complicates matters further: roughly 20% of adults with bipolar disorder also meet criteria for ADHD, meaning both diagnoses can coexist in the same person.

Specialized rating scales can help with the depression side of this puzzle. The Bipolar Depression Rating Scale (BDRS), for example, was designed to pick up features that distinguish bipolar depression from unipolar depression, particularly mixed features like agitation, irritability, and racing thoughts during a depressive episode. One study found that scores on the BDRS “mixed” subscale could predict bipolar depression with a specificity of 82%.¹³

Assessment in Children and Adolescents

Diagnosing bipolar disorder in young people is especially contentious. Children may not describe their internal states clearly, and many symptoms of pediatric bipolar disorder overlap with ADHD, oppositional defiant disorder, and even normal developmental mood swings. The assessment typically relies on a combination of clinical interviews with the child and parents, standardized questionnaires, and careful developmental history. One comparative study of six screening instruments in youth aged 5 to 17 found that parent-report measures consistently outperformed both teacher reports and adolescent self-reports, with parent measures achieving higher classification accuracy across age groups.¹⁴ Combining multiple tests did not meaningfully improve accuracy beyond what a good parent-report measure achieved alone.

The practical takeaway is that parents are often the most reliable informants when it comes to recognizing mood episode patterns in their children, and structured parent-report tools should be a routine part of any pediatric bipolar assessment.¹⁵

Neuropsychological Testing

You might assume that cognitive difficulties in bipolar disorder are limited to active mood episodes, but research consistently shows that people with bipolar disorder perform worse on cognitive tests even when their mood is stable. Multiple meta-analyses have found medium-to-large deficits across attention, processing speed, memory, and executive functioning in people with bipolar disorder who are currently in a euthymic (stable-mood) state.¹⁶ One meta-analysis using individual patient data confirmed impairments across all 11 test measures examined, even after controlling for age, IQ, and gender. Residual mood symptoms accounted for some of this, but not enough to explain the full effect.¹⁷

An interesting and consistent finding is that vocabulary and word-reading ability tend to be spared. People with bipolar disorder generally perform at normal levels on tests of crystallized verbal knowledge, even when they show deficits in other domains.¹⁸ Neuropsychological testing doesn’t diagnose bipolar disorder, but it can help clinicians understand a patient’s functional strengths and weaknesses, guide workplace accommodations, and sometimes clarify the picture when the diagnosis is uncertain.

Suicide Risk Assessment

Bipolar disorder carries one of the highest suicide risks of any psychiatric condition, making risk assessment a non-negotiable part of any evaluation. Clinical assessment for suicide risk should include a mental state examination, identification of known risk factors, evaluation of access to means, and consideration of any preparatory acts.¹⁹ Substance use deserves particular attention. People with both bipolar disorder and an alcohol use disorder are significantly more likely to report suicidal ideation and suicide attempts than those with bipolar disorder alone, even when the number of depressive episodes is the same. In one study, alcohol use disorder remained independently associated with a lifetime history of suicide attempt after controlling for demographics, with an adjusted odds ratio of about 1.6.²⁰ Other substance use disorders and nicotine dependence did not show the same independent link, making alcohol use a particularly important factor to assess.

Primary Care Screening

Most people with unrecognized bipolar disorder are sitting in primary care offices, being treated for depression. A modeling study estimated the economic impact of systematically screening for bipolar disorder in primary care. Compared to no screening, a one-time screening algorithm reduced misdiagnoses from 680 to 260 per modeled cohort and saved over $21 million in direct costs over five years. Even simpler approaches like using the MDQ alone were beneficial, cutting misdiagnoses roughly in half.²¹ Despite this, routine bipolar screening in primary care is not standard practice in most health systems. If you’re being treated for depression and it isn’t improving with standard antidepressants, or if you’ve had periods of unusual energy, reduced sleep need, or impulsive behavior, asking your doctor about bipolar screening is a reasonable step.

Family History and Genetic Risk

A thorough assessment for bipolar disorder always includes a detailed family history. Bipolar disorder is among the most heritable psychiatric conditions, and having a first-degree relative with the illness substantially raises someone’s risk. Researchers have also developed polygenic risk scores (PRS), which aggregate the effects of many small genetic variants to estimate a person’s genetic liability. In studies of children of parents with bipolar disorder, bipolar PRS independently predicted which offspring went on to develop the condition, and the effect was larger in children who also had depression, anxiety, or a parent whose mood disorder started at a younger age.²²

Environment complicates the picture. One study of high-risk families found that higher genetic risk tracked with higher bipolar risk, but only in families with well-functioning environments. In high-conflict families, the expected genetic relationship actually reversed, with the highest risk for bipolar disorder appearing among those with lower polygenic scores.²³ The effect sizes involved are still too small for polygenic risk scores to be clinically useful as a standalone diagnostic tool.²⁴ But they illustrate why asking about family history and early environment remains one of the most informative parts of a clinical assessment.

Biomarkers and Brain Imaging

A common question people ask is whether a brain scan or blood test can diagnose bipolar disorder. The honest answer, as of now, is no. Despite decades of research into potential biomarkers spanning genetics, neuroimaging, inflammation markers, and metabolomics, a comprehensive review concluded that the vast majority of candidate biomarkers are still in early stages of development and none are ready for clinical use.²⁵ An earlier position paper from the International Society for Bipolar Disorders reached a similar conclusion, emphasizing that large collaborative studies are needed before any biomarker could be employed clinically.²⁶ Brain imaging studies do show group-level differences, such as reduced gray matter volume in certain frontal and temporal regions, but these differences are averages across groups, not markers that can identify an individual case. For now, assessment remains a fundamentally clinical process.

Sleep Monitoring and Actigraphy

Sleep disruption is a core feature of bipolar disorder, both as a symptom during episodes and, increasingly, as an early warning sign that an episode is developing. Actigraphy, which involves wearing a small wrist device that tracks movement and sleep-wake patterns over days or weeks, has emerged as a useful objective measurement tool. A systematic review and meta-analysis highlighted actigraphy’s role as an important ambulatory monitoring method for tracking sleep and activity patterns in people with bipolar disorder.²⁷ Clinically, actigraphy isn’t used to make the initial diagnosis, but it can help confirm mood episode timing, detect circadian rhythm disruptions, and provide objective data when a patient’s self-report is unreliable. Some clinicians use it as part of ongoing monitoring to catch early signs of relapse.

This connects to a broader shift toward digital tools. Smartphone-based approaches now collect passive data on sleep timing, physical activity, social interaction, and phone usage to build a picture of someone’s behavioral patterns over time. Early research suggests these “digital signatures” could eventually help predict mood episodes before they fully develop.²⁸ These tools are not part of routine clinical practice yet, but they represent where the field is headed: continuous, real-world monitoring rather than snapshot assessments at clinic visits.

How the Concept of Bipolar Disorder Has Shifted

Assessment tools are only as good as the diagnostic framework behind them, and that framework has changed substantially over the past century. Emil Kraepelin’s original concept of manic-depressive insanity lumped together what we now separate into bipolar and unipolar mood disorders. The split between unipolar and bipolar forms was established through independent work in the 1960s.²⁹ More recently, the emphasis has moved toward a bipolar spectrum, recognizing that milder forms shade into normal temperamental variation. This spectrum view matters for assessment because it means the boundary between “has bipolar disorder” and “has a cyclothymic temperament” is not always crisp. Whether someone falls on one side or the other can depend on which instruments are used, how strictly the clinician applies duration criteria, and whether the person’s hypomanic episodes caused enough impairment to count. It’s a diagnosis where clinical judgment still does a lot of the heavy lifting, and where no questionnaire or interview can fully substitute for a clinician who takes the time to piece together the full picture of someone’s mood history.